BIONET Corp. (TPEX:1784)
Taiwan · Delayed Price · Currency is TWD 103.50
-1.50 (-1.43%)
Dec 31, 2025, 2:31 PM CST
BIONET Market Cap
BIONET has a market cap or net worth of 5.21 billion as of December 31, 2025. Its market cap has increased by 3.06% in one year.
Market Cap
5.21B
Enterprise Value
4.79B
Revenue
1.22B
Ranking
n/a
PE Ratio
74.96
Stock Price
103.50
Market Cap Chart
Since November 3, 2008, BIONET's market cap has increased from 1.14B to 5.21B, an increase of 355.30%. That is a compound annual growth rate of 9.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 5.21B | 29.12% |
| Dec 31, 2024 | 4.03B | 47.30% |
| Dec 29, 2023 | 2.74B | 32.70% |
| Dec 30, 2022 | 2.06B | 9.73% |
| Dec 30, 2021 | 1.88B | -2.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 238.84B |
| PharmaEssentia | 174.75B |
| Lotus Pharmaceutical | 73.63B |
| Heron Neutron Medical | 70.42B |
| Bora Pharmaceuticals Co., LTD. | 60.90B |
| Lin BioScience | 33.13B |
| Lumosa Therapeutics | 31.84B |
| Center Laboratories | 30.94B |